P
Protenus
Cybersecurity · Baltimore, United States · Founded 2014
Protenus - A new approach to protecting patient privacy and defending hospitals against HIPAA violations MoreLess
Established in 2014 by co-founders Nick Culbertson and Robert Lord, Protenus operates within the healthcare technology sector, providing artificial intelligence-driven solutions to mitigate risk for healthcare organizations. The founders' backgrounds are deeply rooted in the intelligence community and data science; Culbertson served as a US Army intelligence officer and Lord was a data scientist at the Johns Hopkins University Applied Physics Laboratory. This experience directly informs the company's approach to sifting through vast amounts of data to detect anomalous behavior, a skill set they translated from national security to patient privacy and security.
The company's core business revolves around its Patient Privacy Monitoring and Drug Diversion Surveillance platform. This platform helps hospitals and health systems protect sensitive patient data and prevent the theft of controlled substances. Protenus serves a client base of healthcare organizations, offering them tools to ensure compliance with regulations like HIPAA and to combat the growing issue of drug diversion within their facilities. The business model is based on providing these risk-reduction solutions as a service, presumably through a subscription or licensing fee structure. The platform analyzes every access to patient data within a hospital's electronic health record system, using AI to identify inappropriate access patterns. For drug diversion, the system scrutinizes the entire medication lifecycle—from procurement to administration—to detect suspicious activities that could indicate theft for personal use or sale.
Protenus has achieved several key milestones, including securing multiple rounds of funding to fuel its growth and product development. For instance, the company raised $21 million in a Series D funding round in 2021, bringing its total funding to over $50 million at the time. Throughout its history, Protenus has garnered industry recognition, being named to various prestigious lists such as the Forbes list of America's Best Startup Employers and Modern Healthcare's Best Places to Work. Keywords: healthcare AI, patient privacy monitoring, drug diversion surveillance, healthcare compliance, risk reduction, electronic health records, data security, health data analytics, HIPAA, controlled substances
Company overview
Protenus company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2014
- Headquarters
- Baltimore, United States
- Employees
- 22
- Open positions
- None listed
- Dealroom signal
- 62.2
Valuation & funding
Protenus funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Jan 2025 | $0 | — | Bluesight | ↗ |
| SERIES DOther financing | Jun 2021 | $21M | $84M | Arthur Ventures · Gaingels · Transformation Capital · LionBird | — |
| SERIES COther financing | Aug 2019 | $17M | $68M | LionBird · Arthur Ventures · Providence Ventures · Kaiser Permanente Ventures | — |
| SERIES BOther financing | Jan 2018 | $11M | $44M | LionBird · Kaiser Permanente Ventures · Arthur Ventures · Cognosante | — |
| SERIES AOther financing | Jul 2017 | $3M | $12M | Kaiser Permanente · LionBird · F-Prime · Kaiser Permanente Ventures | — |
| SERIES AOther financing | Jan 2016 | Arthur Ventures | — | ||
| SEEDOther financing | Jan 2015 | Undisclosed | — | ||
| ANGELOther financing | Sep 2014 | Undisclosed | — | ||
| SEEDOther financing | Apr 2014 | Dreamit Ventures | — | ||
| SEEDOther financing | Jan 2014 | Dreamit Ventures | — |
Growth signals
Protenus website traffic
Latest recorded traffic for Protenus is 910 monthly website visits, down 30% over the last three months. Protenus's team declined 15.4% over the past year.
Comparisons
Protenus compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Protenus's talent
Source: Dealroom Talent Intelligence.
Investors
12 investors on Protenus's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.


Global footprint
Where Protenus has talent and traffic
team presence
In the news
Latest news about Protenus
Recent press, funding announcements, and product moves mentioning Protenus — open to read from the original sources.
Market sentiment
What the market is saying about Protenus
An AI-synthesized read of the highest-engagement posts about Protenus on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Protenus’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.

















